文献速递精神分裂症与精神病性障碍

核受体5A2调控Agrp介导奥氮平诱导的过度进食

Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia.
PubMed 文献 · Mol Psychiatry · 2023-02-10

该研究探讨下丘脑Nr5a2在抗精神病药(AP)所致过度进食和体重增加中的作用。在细胞系中奥氮平剂量依赖性上调Nr5a2和Agrp表达;在小鼠中药理抑制NR5A2可减轻奥氮平诱导的过度进食和体重增加,弓状核Nr5a2敲低部分逆转过度进食;染色质免疫沉淀首次显示NR5A2直接结合Agrp启动子区;单细胞RNA测序确认二者在弓状核部分神经元共表达。

要点

  • 奥氮平在细胞系中剂量依赖性上调Nr5a2和Agrp基因表达。
  • 药理抑制NR5A2可减轻小鼠奥氮平诱导的过度进食和体重增加。
  • NR5A2直接结合Agrp启动子区,弓状核Nr5a2与Agrp共表达。

核心结论

  • Nr5a2是抗精神病药诱导食物摄入的关键机制驱动因素。

研究设计与样本

  • 研究采用下丘脑细胞系、小鼠模型、染色质免疫沉淀和单细胞RNA测序数据分析。

主要发现

  • 在细胞系中,奥氮平处理导致Nr5a2和Agrp基因表达剂量依赖性增加。
  • 在小鼠中,药理抑制NR5A2降低奥氮平诱导的过度进食和体重增加。
  • 弓状核Nr5a2敲低部分逆转奥氮平诱导的过度进食。
  • 染色质免疫沉淀显示NR5A2直接结合Agrp启动子区域。
  • 单细胞RNA测序数据确认Nr5a2和Agrp在弓状核部分神经元中共表达。

临床怎么用

  • 这些发现可为未来临床开发不激活过度进食和体重增加的抗精神病药提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antipsychotic (AP) drugs are efficacious treatments for various psychiatric disorders, but excessive weight gain and subsequent development of metabolic disease remain serious side effects of their use. Increased food intake leads to AP-induced weight gain, but the underlying molecular mechanisms remain unknown. In previous studies, we identified the neuropeptide Agrp and the transcription factor nuclear receptor subfamily 5 group A member 2 (Nr5a2) as significantly upregulated genes in the hypothalamus following AP-induced hyperphagia. While Agrp is expressed specifically in the arcuate nucleus of the hypothalamus and plays a critical role in appetite stimulation, Nr5a2 is expressed in both the CNS and periphery, but its role in food intake behaviors remains unknown. In this study, we investigated the role of hypothalamic Nr5a2 in AP-induced hyperphagia and weight gain. In hypothalamic cell lines, olanzapine treatment resulted in a dose-dependent increase in gene expression of Nr5a2 and Agrp. In mice, the pharmacological inhibition of NR5A2 decreased olanzapine-induced hyperphagia and weight gain, while the knockdown of Nr5a2 in the arcuate nucleus partially reversed olanzapine-induced hyperphagia. Chromatin-immunoprecipitation studies showed for the first time that NR5A2 directly binds to the Agrp promoter region. Lastly, the analysis of single-cell RNA seq data confirms that Nr5a2 and Agrp are co-expressed in a subset of neurons in the arcuate nucleus. In summary, we identify Nr5a2 as a key mechanistic driver of AP-induced food intake. These findings can inform future clinical development of APs that do not activate hyperphagia and weight gain.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zapata RC, Zhang D, Libster A, et al. Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia. Mol Psychiatry. 2023. PMID: 36765131. doi:10.1038/s41380-023-01981-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。